Basecamp Research

Raised $140M in a Series C round, announced 23 September 2026.

Round

Basecamp Research raised an oversubscribed Series C led by S32 to train EDEN models and advance AI-designed therapeutics toward clinical development.

Amount
$140M
Stage
Series C
Announced
23 September 2026
Lead
S32
Other investors
Menlo Ventures' Anthology Fund, Catalio Capital Management, European Tech Collective, Firebrand River Capital, Inception Fund, King Philanthropies, NATO Innovation Fund, NVIDIA, PostScriptum, Redalpine, The Rockefeller Foundation
Use of funds
Train a new generation of EDEN models and advance a pipeline of AI-designed therapeutics towards clinical development.
Checked
Amount and date matched across 3 press sources

Company

Designs therapeutics using biological foundation models and proprietary genetic data

Based in
United Kingdom
Sector
Health
Website
basecamp-research.com ↗

Founder

  • Glen Gowersco-founder and CEO

Sources and links

Sources
Basecamp Research raises $140M to advance AI-designed therapeutics newswire.ca
Basecamp Research raises $140M to advance AI-designed therapeutics prnewswire.com
Basecamp Research raises $140M to advance AI-designed therapeutics prnewswire.com
Website
basecamp-research.com ↗
MediaBoost

Just raised?

MediaBoost gets your round in front of the press, future hires and your next investors.

Announce your round with MediaBoost